# Adjuvant Treatment of Concurrent RT and CAPOX or Capecitabine Alone for Stage II and III Rectal Cancer

> **NCT00714077** · — · UNKNOWN · sponsor: **Chinese Academy of Medical Sciences** · enrollment: 570 (estimated)

## Conditions studied

- Rectal Neoplasms

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00714077
- **Lead sponsor:** Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-04
- **Primary completion:** 2018-01
- **Final completion:** 2018-06
- **Target enrollment:** 570 (ESTIMATED)
- **Last updated:** 2016-02-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00714077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00714077, "Adjuvant Treatment of Concurrent RT and CAPOX or Capecitabine Alone for Stage II and III Rectal Cancer". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00714077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*